Refining Targeted Therapy Opportunities for BRAF-Mutant Melanoma

被引：5
|
作者：
Jenkins, Russell W. [1 ,2 ]
Barbie, David A. [1 ]
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Div Med Oncol, Boston, MA USA
来源：
CANCER DISCOVERY | 2017年 / 7卷 / 08期
关键词：
RESISTANCE; INHIBITORS; MITF; NRAS;
D O I：
10.1158/2159-8290.CD-17-0607
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Identifying molecular and cellular features associated with resistance to targeted BRAF/MAPK pathway inhibition may guide development of novel therapeutic approaches. Integrated, comparative analysis of genomic and functional data in sensitive and resistant cell lines unveils novel targetable regulators of resistance to MAPK pathway inhibition in melanoma.
引用
收藏
页码：799 / 801
页数：3
相关论文
共 50 条
  • [21] Immunotherapy First for BRAF-Mutant Melanoma
    Rose, Suzanne
    CANCER DISCOVERY, 2022, 12 (01) : 10 - 10
  • [22] Resistance to BRAF and MEK inhibitors in BRAF-mutant melanoma
    Patel, Hima
    Yacoub, Nour
    Garrett, Joan T.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB43 - AB43
  • [23] Immunotherapy or Molecularly Targeted Therapy: What Is the Best Initial Treatment for Stage IV BRAF-Mutant Melanoma?
    Gibney, Geoffrey T.
    Atkins, Michael B.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (07)
  • [24] Activity of targeted therapy after failure of first-line immunotherapy in BRAF-mutant metastatic melanoma
    Xia, Cathy Yi
    Wang, Daniel Ying
    Mason, Robert
    Smith, Jessica Louise
    McKean, Meredith Ann
    Lo, Serigne
    Guminski, Alexander David
    Long, Georgina V.
    Carlino, Matteo S.
    Atkinson, Victoria
    Millward, Michael
    McQuade, Jennifer Leigh
    Amaria, Rodabe Navroze
    Johnson, Douglas Buckner
    Menzies, Alexander M.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [25] Advancements and Challenges in Personalized Therapy for BRAF-Mutant Melanoma: A Comprehensive Review
    Shebrain, Abdulaziz
    Idris, Omer A.
    Jawad, Ali
    Zhang, Tiantian
    Xing, Yan
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (18)
  • [26] Novel combination therapies for BRAF-mutant melanoma
    Grant A McArthur
    Journal of Translational Medicine, 13 (Suppl 1)
  • [27] Management of a Patient With Advanced BRAF-Mutant Melanoma
    Ashworth, Michelle T.
    Daud, Adil
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2014, 12 (03): : 315 - 319
  • [28] The perspectives and challenges in BRAF-mutant advanced melanoma
    Romanova, Alexandra
    Balandina, Anastasiia
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 45 - 45
  • [29] Current Advances in the Treatment of BRAF-Mutant Melanoma
    Patel, Hima
    Yacoub, Nour
    Mishra, Rosalin
    White, Aaron
    Yuan, Long
    Alanazi, Samar
    Garrett, Joan T.
    CANCERS, 2020, 12 (02)
  • [30] Drug Combos Validated in BRAF-Mutant Melanoma
    不详
    CANCER DISCOVERY, 2014, 4 (12) : 1361 - 1362
12345